Diagnostic and therapeutic difficulties of pediatric encephalitis with a N Methyl D Aspartate in Libreville: about three cases.

Read full text
Authors: Angéla Mekame Méyé, Larissa Tecle Midili, Léandre Mouelé Nguélé, Raïssa Koumba Maniaga, Simon Ategbo
Cited by: 0

Abstract

Anti-NMDAR antibody encephalitis is an autoimmune neurological disease, which is defined as an inflammation of the brain due to antibodies attached to N-Methyl-D-Aspartate receptors. This is the most common autoimmune encephalitis and a neurological emergency. It accounts for 4% of all encephalitis cases, making it the fifth most common cause after herpes simplex virus and varicella-zoster virus (VZV) infections. It is rare in pediatrics, with an incidence ranging from 0.07 to 0.085 per 100,000 children in Europe, but in Africa it remains underdiagnosed due to the very high cost of antibody testing in cerebrospinal fluid (CSF) and treatment. It is characterized by neuropsychiatric symptoms and leads to serious cognitive and psychomotor sequelae if left untreated. Therefore, we share our experience with three pediatric cases to clarify the circumstances of their onset, the various clinical signs, and finally, to highlight the diagnostic and management difficulties we encountered in our setting.

Fields of Study & Subjects

Autoimmune Neurological Disorders and Treatments Neurological Complications and Syndromes Amino Acid Enzymes and Metabolism

Publication details

Journal / source
World Journal of Advanced Research and Reviews
Volume
29
Issue
1
Pages
450–455
Publication date
10 January 2026